Clinical Trial Update: Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating the pharmacodynamics of a fixed-dose combination eye drop containing tropicamide 0.34% and phenylephrine hydrochlorid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mydriasis

Drugs mentioned

• PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE)
• Tropicamide (tropicamide)

Snippet

Sponsor: Unither Pharmaceuticals, France | Conditions: Mydriasis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING